Jeffrey S. Parkin

Array ( [id] => 515887 [patent_doc_number] => 07189402 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Live vaccine for human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 09/244195 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13382 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189402.pdf [firstpage_image] =>[orig_patent_app_number] => 09244195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080305 [patent_doc_number] => 20020081566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'HIV PROTEIN EPITOPES IMMUNOLOGICALLY HOMOLOGOUS TO HLA' [patent_app_type] => new [patent_app_number] => 09/243079 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3848 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081566.pdf [firstpage_image] =>[orig_patent_app_number] => 09243079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015585 [patent_doc_number] => 20020102540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'FUNCTIONAL DNA CLONE FOR HEPATITIS C VIRUS (HCV) AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/238076 [patent_app_country] => US [patent_app_date] => 1999-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 37067 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102540.pdf [firstpage_image] =>[orig_patent_app_number] => 09238076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573851 [patent_doc_number] => 06468539 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Protein targeting into HIV virions based on HIV-1 VPR fusion molecules' [patent_app_type] => B1 [patent_app_number] => 09/454156 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 7012 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468539.pdf [firstpage_image] =>[orig_patent_app_number] => 09454156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579356 [patent_doc_number] => 06448389 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Human cytomegalovirus DNA constructs and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/171699 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22365 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448389.pdf [firstpage_image] =>[orig_patent_app_number] => 09171699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1109843 [patent_doc_number] => 06805867 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Bovine rotavirus genes' [patent_app_type] => B1 [patent_app_number] => 09/232338 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12109 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/805/06805867.pdf [firstpage_image] =>[orig_patent_app_number] => 09232338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 401088 [patent_doc_number] => 07291452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-11-06 [patent_title] => 'Erythrovirus and its applications' [patent_app_type] => utility [patent_app_number] => 09/555640 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 8303 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291452.pdf [firstpage_image] =>[orig_patent_app_number] => 09555640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946431 [patent_doc_number] => 06964763 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-15 [patent_title] => 'Methods and compositions for inhibiting HIV infectivity and blocking chemokine activity' [patent_app_type] => utility [patent_app_number] => 09/555090 [patent_app_country] => US [patent_app_date] => 1998-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 16697 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964763.pdf [firstpage_image] =>[orig_patent_app_number] => 09555090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416284 [patent_doc_number] => 06514691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2' [patent_app_type] => B1 [patent_app_number] => 09/191384 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 1 [patent_no_of_words] => 7412 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514691.pdf [firstpage_image] =>[orig_patent_app_number] => 09191384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 718837 [patent_doc_number] => 07048929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-23 [patent_title] => 'Stabilized primate lentivirus envelope glycoproteins' [patent_app_type] => utility [patent_app_number] => 09/446820 [patent_app_country] => US [patent_app_date] => 1998-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 20887 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/048/07048929.pdf [firstpage_image] =>[orig_patent_app_number] => 09446820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331791 [patent_doc_number] => 06596539 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Modification of virus tropism and host range by viral genome shuffling' [patent_app_type] => B1 [patent_app_number] => 09/183037 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 37031 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596539.pdf [firstpage_image] =>[orig_patent_app_number] => 09183037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602522 [patent_doc_number] => 06432701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Derived tyrosine hydroxylase gene expression system' [patent_app_type] => B1 [patent_app_number] => 09/171162 [patent_app_country] => US [patent_app_date] => 1998-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7120 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432701.pdf [firstpage_image] =>[orig_patent_app_number] => 09171162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1204640 [patent_doc_number] => 06716429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain' [patent_app_type] => B1 [patent_app_number] => 09/164880 [patent_app_country] => US [patent_app_date] => 1998-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12116 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716429.pdf [firstpage_image] =>[orig_patent_app_number] => 09164880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261866 [patent_doc_number] => 06306401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Genetically-engineered sindbis virus with modified E2 Glycoprotein and altered host-range phenotype' [patent_app_type] => 1 [patent_app_number] => 9/157270 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10036 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306401.pdf [firstpage_image] =>[orig_patent_app_number] => 157270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640024 [patent_doc_number] => 06395891 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Methods and compositions for combating HIV infection' [patent_app_type] => B1 [patent_app_number] => 09/150812 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 31 [patent_no_of_words] => 26068 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395891.pdf [firstpage_image] =>[orig_patent_app_number] => 09150812 [rel_patent_id] =>[rel_patent_doc_number] =>)